Evidence-based medicine for cardiologists and oncologists
MedicBK services improve adherence to CPGs
Identify the safest and the most efficient treatments for every particular patient
Training Simulator

- More than 100 valid clinical cases for every nosology presented

- Testing and training for doctors and practitioners

- Evaluation of clinical practise guideline (CPG) adherence

- Adherence rating

Clinical Decision Support System (CDSS)

- Evaluating treatments upon every individual patient

- Fast calculation - results available in 2 minutes

- Unbiased and objective information - all data is based on CPGs

Producing high-quality evidence-based medical data in under 5 minutes.

An equal analysis made by a health professional takes 5-40 hours

Data inclusion criteria and its analysis are made with the same methodology as the one used by Cochrane

Databases trusted by doctors
- Using recognised clinical practice guidelines
- Calculating therapies based on full clinical research databases
Patient’s characteristics by nosology
- Comprehensive check-lists used to evaluate patients and assign examinations
Patient’s evaluation by risk factors and scales
- Choosing an optimal therapy considering a patient’s risk factors and contraindications
Prognosing adverse events
- Evaluating treatments efficiency and safety for every patient
MedicBK automatically determines patients' most significant risk factors, their absolute and relative contraindications. It provides treatment options based on current clinical practise guidelines (ESC & AHA for cardiology, NCCN for oncology).

The program uses a digital patient model to calculate efficiency and safety of available drugs and interventions in comparison with each other and upon a patient's health profile.

The digital model is built on databases from multi-centre randomised controlled trials.

Training Simulator and Clinical Decision Support System are available for
Chrome, Firefox, Safari

Arterial hypertension
Atrial fibrillation
Heart failure
Coronary heart disease (Dec.2020)

Breast cancer (available Q1 2021)

About us

It took 2+ years to develop the current version.

MedicBK’s digital patient model was developed by research doctors experienced in CPGs, specialists in modelling and meta-analysis. It was made in close cooperation with EHRA in Russia.

The Cardiology release was highly appreciated by Russian and Western experts, including the President of EHRA.

The service got validation by Russian healthcare system after being tested in the National Medical Research Centre NA Almazov. Clinical study audition of the Centre's registry data showed that using MedicBK services led to a significant change in treatment tactics that improved clinical outcomes prediction.

INTELLIGENCE research outcomes showed a significant impact of MedicBK on treatment tactics that led to forecast outcomes improvement

A retrospective assessment of the adequacy of treatment choice in patients made by MedicBK, National Medical Research Centre NA Almazov, 2020 Identifier: NCT04564118
92% of the initial treatments adhered to CPG
77% of drugs/interventions were changed in relation to initial prescriptions
14 - an average amount of therapeutic combinations available for arterial hypertension (2-36 for every patient), the total amount of INN - 42

31% more drugs were prescribed (that improved an overall CPG adherence)

advanced technologies for a widespread of evidence-based medicine in daily clinical practice

Made on